Function first: a powerful approach to post-genomic drug discovery

In the post-genomic era, pharmaceutical researchers must evaluate vast numbers of protein sequences and formulate novel, intelligent strategies for identifying valid targets and discovering leads against them. The identification of small molecules that selectively target proteins or protein families...

Full description

Saved in:
Bibliographic Details
Published in:Drug Discovery Today 2002-08, Vol.7 (16), p.865-871
Main Authors: Betz, Stephen F., Baxter, Susan M., Fetrow, Jacquelyn S.
Format: Article
Language:English
Subjects:
active site
Biological and medical sciences
functional site
General pharmacology
Medical sciences
Pharmaceutical technology. Pharmaceutical industry
Pharmacology - trends
Pharmacology. Drug treatments
protein structure
Proteins - chemistry
Proteomics
structural proteomics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the post-genomic era, pharmaceutical researchers must evaluate vast numbers of protein sequences and formulate novel, intelligent strategies for identifying valid targets and discovering leads against them. The identification of small molecules that selectively target proteins or protein families will be aided by knowing the function and/or the structure of the target(s). By identifying protein function first, efficiencies are gained that allow subsequent focus of resources on particular protein families of interest. This article reviews current proteomic-scale approaches to identifying function as a way of accelerating lead discovery.
ISSN:1359-6446
1878-5832
DOI:10.1016/S1359-6446(02)02398-X